Riskpilot← Back to searchSign inGet full accessPDG22 AS
ASActiveOrg 921148941Hegdehaugsveien 36B, 0352 OsloOther real estate activities on a fee or contract basis · NACE 6832Est. 20180 employees
Revenue 2023
NOK 686K
+4% vs 2022
EBITDA margin
75.5%
-7% vs 2022
Equity ratio
33.2%
Financial strength
Net profit 2023
NOK 330K
-3% vs 2022
| Revenue | NOK 686K | +4% |
| EBITDA | NOK 518K | -7% |
| Net profit | NOK 330K | -3% |
| Total assets | NOK 3,7M | -3% |
| Equity | NOK 1,2M | +36% |
| Employees | 0 | — |
Legal name
PDG22 AS
Org number
921148941
Legal form
Aksjeselskap
NACE code
6832 · Other real estate activities on a fee or contract basis
Founded
11. juli 2018
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å eie, forvalte og leie ut fast eiendom og alt som står i forbindelse med dette.
Address
Hegdehaugsveien 36B, 0352 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 591 | 599 | 612 | 661 | 686 |
| Staff expenses | −0 | −0 | −13 | −23 | 2 | −0 |
| EBITDA | −16 | 485 | 431 | 447 | 555 | 518 |
| Depreciation & amort. | −0 | −95 | −95 | −95 | −95 | −95 |
| EBIT | −16 | 390 | 335 | 352 | 459 | 422 |
| Net financials | 0 | −92 | −84 | −63 | −24 | 1 |
| Profit before tax | −16 | 298 | 252 | 289 | 436 | 423 |
| Tax | −3 | 63 | 55 | −46 | 96 | 93 |
| Net profit | −12 | 235 | 196 | 334 | 340 | 330 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Total assets | 33 | 4 096 | 4 260 | 4 083 | 3 836 | 3 724 |
| Equity | 18 | 35 | 231 | 566 | 905 | 1 236 |
| Long-term debt | 0 | 3 712 | 3 603 | 3 420 | 2 928 | 2 403 |
| Short-term debt | 16 | 349 | 426 | 97 | 2 | 86 |
| Total debt | 16 | 4 061 | 4 029 | 3 517 | 2 930 | 2 488 |
EBITDA margin
75.5%
This company
15.8%
Market median
+378% vs market
20182023
Equity ratio
33.2%
This company
38.2%
Market median
+13% vs market
20182023
Return on equity
26.7%
This company
18.4%
Market median
+45% vs market
20182023
Net profit margin
48.1%
This company
8.1%
Market median
+494% vs market
20182023
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20182023
Debt / equity
2.01×
This company
0.62×
Market median
-224% vs market
20182023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-05-22 – 2018-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Oslo Dermatology As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Oslo Dermatology As
PDG22 AS Board members of PDG22 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maya Tigalonova-Waliszewska | Board of Directors | 0 companies |
| Georg Tigalonov-Bjerke | Board of Directors | 0 companies |
| Jens Roar Bjerke | Chairman | 0 companies |
| Bård Einar Levorsen | Chairman | 0 companies |